Hypoglycemia is the most potent stimulus, directly sensed by alpha cells and mediated by sympathetic nervous system activation. Disruption of this equilibrium, where glucagon secretion remains inappropriately high during hyperglycemia, is a hallmark of type 2 diabetes and contributes significantly to fasting hyperglycemia.
Glucagon Glucose Balance in Type 1 Diabetes: Understanding the Impact
Clinical Significance and Pathophysiology Dysregulation of the glucagon-glucose axis is central to the pathophysiology of diabetes mellitus. Conversely, hyperglycemia, insulin, and incretin hormones like GLP-1 act as inhibitors.
Furthermore, the risk of severe hypoglycemia in diabetic patients is often linked to pharmacologic insulin or sulfonylurea therapy unmasking the counter-regulatory glucagon response. For instance, GLP-1 receptor agonists and amylin analogs enhance insulin secretion, suppress glucagon release, and slow gastric emptying.
Glucagon Glucose Balance in Type 1 Diabetes and Its Clinical Impact
In a healthy individual, this balance acts like a thermostat, fine-tuning glucose levels to meet cellular energy demands. Autonomic signals from the gut during meal anticipation ("cephalic phase") also prime alpha cells for impending nutrient influx.
More About Glucagon glucose
Looking at Glucagon glucose from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Glucagon glucose can make the topic easier to follow by connecting earlier points with a few simple takeaways.
